Detalhe da pesquisa
1.
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.
Clin Cancer Res
; 30(2): 379-388, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939133
2.
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas.
Nat Commun
; 15(1): 4698, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38844770
3.
Evolution of Transradial Access for Mechanical Thrombectomy-A Single Center Experience.
Neurosurgery
; 92(4): 795-802, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512809
4.
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.
Nat Commun
; 14(1): 1566, 2023 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949040
5.
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Nat Med
; 25(12): 1839-1842, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768065
6.
Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas.
Adv Oncol
; 3(1): 77-86, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37860079